Detalles de la búsqueda
1.
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
BMC Neurol
; 15: 170, 2015 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26395989
2.
Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study.
Int J Mol Sci
; 16(7): 15271-86, 2015 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26154767
3.
Impact of interferon beta exposure on birth outcome and child development - Results from the post-authorisation safety study PRIMA.
Mult Scler Relat Disord
; 77: 104844, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37393802
4.
Pregnancy outcomes in female multiple sclerosis patients exposed to intramuscular interferon beta-1a or peginterferon beta-1a reported in a German Patient Support Programme - results from the non-interventional post-authorization safety study PRIMA.
Ther Adv Neurol Disord
; 16: 17562864231214041, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38107443
Resultados
1 -
4
de 4
1
Próxima >
>>